Partnerships & Mergers

The upgraded laboratory streamlines sample processing from reception through advanced analysis and genetic sequencing.

This initiative aligns with the Ministry’s National Cancer Plan 2023–2028 and represents a key step in advancing Lebanon’s cancer control strategy.

This partnership marks a major step in advancing clinical excellence, operational efficiency, and innovation in one of the Middle East’s most rapidly evolving medical markets.

This new alliance stands out as a bold and unconventional initiative that blends healthcare innovation with creative design thinking.

The collaboration is designed to strengthen Everest’s commercial operations in China while expanding its presence in the cardiovascular disease market.

The collaboration reinforces Bupa CareConnect’s leadership in the Kingdom’s digital healthcare transformation and aligns with the national objectives of Saudi Vision 2030.

The partnership is built on five guiding principles: Member State Ownership and Leadership, Equity and Access, Sustainability and Sovereignty, Transparency and Accountability, and Innovation for Impact.

The collaboration brings together IROS’s clinical research expertise with BioSapien’s innovative cancer treatment technology to advance precision medicine in the region.

The management contract forms part of Seha Group’s broader expansion strategy, which emphasizes development and operational excellence rather than traditional acquisition models.

AGC Biologics now offers the ATUM transposase-based platform as part of its growing portfolio of cell line development solutions.